Company Research Report: Institut für Interventionelle Schmerzmedizin SZ AG
1. Company Overview
Name
Institut für Interventionelle Schmerzmedizin SZ AG (ISSZ)
Mission
No information is available.
Founded and Founders
No specific founding date is provided. The practice was officially opened on May 3rd, 2024.
Key People
- Dr. med. Jan Ludwigs: Facharzt Anästhesiologie FMH, Facharzt Interventionelle Schmerztherapie SSIPM, Facharzt POCUS Interventionelle Schmerztherapie SGUM, SPS Schmerzspezialist.
- Dr. med. Daniel Friis DESAIC eMBA: Facharzt Anästhesiologie FMH, Facharzt Interventionelle Schmerztherapie SSIPM, Facharzt POCUS Interventionelle Schmerztherapie SGUM.
Headquarters
Churerstrasse 82, 8808 Pfäffikon SZ, Switzerland
Number of Employees
No specific details on the number of employees are mentioned.
Revenue
No information is available.
Known For
The company is specialized in evidence-based and targeted pain medical care, focusing largely on patients with chronic pain. They use classical medical methods combined with precision image-guided procedures like ultrasound and X-ray guided infiltrations to provide effective pain relief.
2. Products
Products Offered
The ISSZ specializes in interventional medical procedures for the diagnosis and treatment of both acute and chronic pain conditions.
High Level Description
- Diagnostics: Classical medical methods including anamnesis, physical examinations, and imaging.
- Interventional Procedures: They include targeted infiltrations under ultrasound and/or X-ray guidance. Additionally, neuromodulation and neuroablative techniques such as spinal cord stimulation are utilized.
Key Features of Each Product
- Injections under Imaging Guidance: Ensures the precise placement of injections to maximize treatment safety and minimize potential complications.
- Neuromodulation: Includes spinal cord stimulation and other minimally invasive, reversible procedures for pain management.
- Image-Guided Techniques: Enhance treatment safety and efficacy by leveraging technology to accurately target affected areas.
3. Recent Developments
Recent Developments in the Company
- Cooperation with UniversitätsSpital Zürich: The ISSZ has established a formal partnership with the UniversitätsSpital Zürich, where their physicians are involved as mandated physicians for neuromodulation at the Clinic for Neurosurgery.
New Products Launched
No information about new product launches.
New Features Added to Existing Products
- Neuromodulation Techniques: Continued development and application of innovative neuromodulation techniques such as spinal cord stimulation, which influence spinal pain signal transmission through electrical impulses.
New Partnerships
- UniversitätsSpital Zürich: This partnership enhances collaboration that has existed over several years and signifies a deeper integration of specialization and expertise in the field of neuromodulative pain treatment.
This report is based on the data available. For any additional information or updates, contacting the company directly or visiting their official site is recommended.
